Thomas Opladen
- Clinical Biochemistry top 0.2%
- Metabolism and Genetic Disorders 50
- Biochemistry top 2%
- Amino Acid Enzymes and Metabolism 14
- Rheumatology top 2%
- Folate and B Vitamins Research 10
- Genetics top 5%
- Genetics and Neurodevelopmental Disorders 9
-
- Genetic Neurodegenerative Diseases 12
-
- Mitochondrial Function and Pathology 9
- Biochemical and Molecular Research 9
-
- Neonatal Health and Biochemistry 6
- Co-authors
- Nenad BlauGeorg F. HoffmannV. RamaekersMartin HäuslerStefan KölkerBirgit AssmannJeffrey M. SequeiraSheldon P. Rothenberg
- Journals
- Journal of Inherited Metabolic Disease (17 papers)Molecular Genetics and Metabolism (12 papers)Stem Cell Research (5 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Thomas Opladen
79 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 107
- Clinical Biochemistry 860
- Biochemistry 271
- Rheumatology 378
- Genetics 478
- Cellular and Molecular Neuroscience 290
Countries citing papers authored by Thomas Opladen
This map shows the geographic impact of Thomas Opladen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Opladen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Opladen more than expected).
Fields of papers citing papers by Thomas Opladen
This network shows the impact of papers produced by Thomas Opladen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Opladen. The network helps show where Thomas Opladen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Opladen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 16 | |
| 12 | 2020 | 5 | |
| 13 | 2020 | 8 | |
| 14 | 2017 | 34 | |
| 15 | 2017 | 156 | |
| 16 | 2016 | 39 | |
| 17 | 2011 | 27 | |
| 18 | 2010 | 24 | |
| 19 | 2005 | 16 | |
| 20 | 2003 | 73 |
About Thomas Opladen
Thomas Opladen is a scholar working on Clinical Biochemistry, Biochemistry, Rheumatology, Cellular and Molecular Neuroscience and Pediatrics, Perinatology and Child Health, having authored 84 papers that have together received 1.9k indexed citations. Recurring topics across this work include Metabolism and Genetic Disorders (50 papers), Amino Acid Enzymes and Metabolism (14 papers), Genetic Neurodegenerative Diseases (12 papers), Folate and B Vitamins Research (10 papers), Mitochondrial Function and Pathology (9 papers), Biochemical and Molecular Research (9 papers), Genetics and Neurodevelopmental Disorders (9 papers) and Neonatal Health and Biochemistry (6 papers). The work is most often cited by research in Clinical Biochemistry (860 citations), Biochemistry (271 citations), Rheumatology (378 citations), Genetics (478 citations) and Cellular and Molecular Neuroscience (290 citations). Thomas Opladen has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Nenad Blau, Georg F. Hoffmann, V. Ramaekers, Martin Häusler, Stefan Kölker, Birgit Assmann, Jeffrey M. Sequeira, Sheldon P. Rothenberg, Sabine Jung‐Klawitter and Jacob Selhub. Their work appears in journals such as Journal of Inherited Metabolic Disease, Molecular Genetics and Metabolism, Stem Cell Research, Neuropediatrics and Orphanet Journal of Rare Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.